Management of implantable cardioverter defibrillators in end-of-life care.
about
Life-saving devices reach the end of life with heart failure2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of theEthics in the treatment of advanced heart failure: palliative care and end-of-life issues.Hospice Use Following Implantable Cardioverter-Defibrillator Implantation in Older Patients: Results From the National Cardiovascular Data Registry.Patient expectations from implantable defibrillators to prevent death in heart failure.Patient preferences for deactivation of implantable cardioverter-defibrillators.Brief communication: Management of implantable cardioverter-defibrillators in hospice: A nationwide survey.Short-term mortality and cost associated with cardiac device implantation in patients hospitalized with heart failure.Age differences in the use of implantable cardioverter-defibrillators among older patients hospitalized with heart failurePatient and cardiologist perceptions on decision making for implantable cardioverter-defibrillators: a qualitative study.Perspectives on withdrawing pacemaker and implantable cardioverter-defibrillator therapies at end of life: results of a survey of medical and legal professionals and patients.A study to improve communication between clinicians and patients with advanced heart failure: methods and challenges behind the working to improve discussions about defibrillator management trial.Barriers to conversations about deactivation of implantable defibrillators in seriously ill patients: results of a nationwide survey comparing cardiology specialists to primary care physicians.Features and outcomes of patients who underwent cardiac device deactivationMaking decisions about implantable cardioverter-defibrillators from implantation to end of life: an integrative review of patients' perspectives.Patients' perspectives on end-of-life issues and implantable cardioverter defibrillators.Cardiac implantable electrical devices: bioethics and management issues near the end of lifeImplantable Cardioverter-Defibrillator Use in Older Adults: Proceedings of a Hartford Change AGEnts SymposiumCritical appraisal of cardiac implantable electronic devices: complications and managementThe deactivation of implantable cardioverter-defibrillators: medical, ethical, practical, and legal considerations.Spiritual well-being may buffer psychological distress in patients with implantable cardioverter defibrillators (ICD)."That's like an act of suicide" patients' attitudes toward deactivation of implantable defibrillators"It's like crossing a bridge" complexities preventing physicians from discussing deactivation of implantable defibrillators at the end of life.Palliation in heart failure: when less and more are more.Quality of death: implantable cardioverter defibrillators and proactive care.Adverse experiences with implantable defibrillators in Oregon hospicesDeactivation of pacemakers and implantable cardioverter-defibrillatorsManaging beyond an uncertain illness trajectory: palliative care in advanced heart failure.Resynchronization: considering device-based cardiac therapy in older adults.Patient perceptions of implantable cardioverter-defibrillator deactivation discussions: A qualitative study.Informed consent in cardiac resynchronization therapy: what should be said?The use of positive inotropes in end-of-life heart failure care.Cardiac care for older adults. Time for a new paradigmThe use of advance directives among patients with implantable cardioverter defibrillatorsEffective management of ICD patient psychosocial issues and patient critical events.A literature review comparing the experiences and emergent needs of adult patients with permanent pacemakers (PPMs) and implantable cardioverter defibrillators (ICDs).A literature review: Advance directives and patients with implantable cardioverter defibrillators.End-of-life options for patients with advanced heart failure.EHRA Expert Consensus Statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapy.Management of patients receiving implantable cardiac defibrillator shocks: recommendations for acute and long-term patient management.
P2860
Q27021600-988E391E-08B0-4040-8A59-7FB579CDC5A8Q28087002-5E010D7D-108D-4B64-BCEF-3940B847B9E3Q30226406-CFBFF31A-A61D-4EE1-9B4B-35C0B8BBA6C9Q31063536-145644C0-A3B6-42F1-8781-28A4CBFB8483Q33158361-220D53E8-CED6-4F25-AC0C-2E9A9B56A855Q33598449-FAC55280-170F-41F0-90A6-E5454DF6143DQ33704079-4AF08B61-4BAF-4E1C-808D-0BF680C33B45Q33735354-6A25DA7E-D6A4-4E13-9EC2-EC59F93A501AQ33828109-5189C03C-E9C2-4508-BC27-48B2B0BAA7BCQ34040404-8D5A44EA-95BF-47A9-8828-10CABF63A1F0Q34252394-3DB540C8-3856-4F0E-A8BA-E2F7905C7FABQ34381466-A3059B8D-80F6-442B-A36C-19C6EF206709Q34688395-859B6686-6FC2-4FFD-B362-4A193A0B1265Q34703695-28C4BD8B-817C-4C1F-926C-FE4194BDCDC7Q35131582-933376EB-A94A-480A-9BB8-C80AEBAB641EQ35196273-390E6FE5-5E5C-415F-A113-58579690FB12Q35619774-A31ACED1-3B4B-4C02-A1E0-560B25BF9465Q35883082-6446A89A-3C59-4527-A094-478ADA6F5FDCQ36160503-23B3E259-280B-40EB-8EE0-0A97AA392683Q36241346-33DE2D63-0417-4C14-AAF4-3A91D46E90F6Q36292072-F28C3E7B-A2AD-4206-8C0F-C8C09B7767AAQ36293505-1D2193B5-87DE-4A7D-8D5A-A240A9718CA7Q36293515-E63EBD27-699D-476A-9F33-DC389B083AE2Q36435448-E9CD5CCF-DF60-4140-BD9F-C75392F72E69Q36511345-9B428840-9C69-4BFE-85AE-8F482158BBF3Q36627456-393D787D-4FAC-4114-8428-059A3A889618Q36642617-99FCC835-7E18-4CCE-B309-903ACE90BF49Q36758286-E4A16262-643C-4900-849E-AE282B1A0D6FQ36773259-B930D8E2-27E6-4392-8D0C-917A35FE7555Q36793804-F58EF752-6E45-4122-871C-81AB1D29C161Q36810251-CD709401-F7A0-4EEC-BE63-D7153BC13F3AQ36947437-596957EF-2BD5-4E7B-9060-464DF0905324Q37088475-1C2D696A-6D13-41BC-8577-121ECDB7D3D7Q37429247-E351CAB6-5EEE-4F6F-AB6A-CFF41CB79F9FQ37534788-1F17D7BA-1723-4B8E-9AA4-58536CDEDCD0Q37755440-A4DEF057-1BE0-4DEF-8CFC-82ECABB2C06EQ37760601-7B0B4F82-52CB-4B46-9DFE-77FA80E4A02BQ37768379-49E283B8-12D6-4F80-B41A-F9A887AA412AQ37776977-B2955579-2F8E-4890-8ADD-AF49889788C4Q37803046-91EC6906-7200-4D49-A03B-B555F56A5D69
P2860
Management of implantable cardioverter defibrillators in end-of-life care.
description
2004 nî lūn-bûn
@nan
2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Management of implantable cardioverter defibrillators in end-of-life care.
@ast
Management of implantable cardioverter defibrillators in end-of-life care.
@en
Management of implantable cardioverter defibrillators in end-of-life care.
@nl
type
label
Management of implantable cardioverter defibrillators in end-of-life care.
@ast
Management of implantable cardioverter defibrillators in end-of-life care.
@en
Management of implantable cardioverter defibrillators in end-of-life care.
@nl
prefLabel
Management of implantable cardioverter defibrillators in end-of-life care.
@ast
Management of implantable cardioverter defibrillators in end-of-life care.
@en
Management of implantable cardioverter defibrillators in end-of-life care.
@nl
P2093
P1476
Management of implantable cardioverter defibrillators in end-of-life care.
@en
P2093
Elizabeth Bradley
Joanne Lynn
Nathan E Goldstein
Rachel Lampert
P304
P356
10.7326/0003-4819-141-11-200412070-00006
P407
P577
2004-12-01T00:00:00Z